Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and Mitomycin C in First-Line Metastatic Breast Cancer
NCT01196455Phase 2Unknown
- Sponsor
- Croatian Cooperative Group for Clinical Research in Oncology
- Start
- Mar 2006
- Primary completion
- Apr 2011
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, mitomycin c in breast cancer, sponsored by Croatian Cooperative Group for Clinical Research in Oncology. Status: unknown.
02
Drugs
capecitabinemitomycin c
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01196455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196455.